Results 211 to 220 of about 204,272 (330)

Two‐year outcomes of a cardiac microcurrent device in chronic heart failure: A first‐in‐human pilot study

ESC Heart Failure, EarlyView.
Abstract Aims In heart failure patients, altered myocardial electrical fields linked to oedema may impair left ventricular function. While short‐term use of implanted microcurrent generators (C‐MIC) has shown promise, long‐term effects remain unclear.
Dragana B. Kosevic, Una Radak, Petar Vukovic, Jan D. Schmitto, Kersten Brandes, Peter Goettel, Hans‐Dirk Duengen, Elvis Tahirovic, Marija Zdravkovic, Johannes Mueller, Faouzi Kallel, Marat Fudim, Stefan D. Anker, Jesus Eduardo Rame, Miodrag Peric   +14 more
wiley   +1 more source

The association between the use of angiotensin-converting enzyme inhibitors /angiotensin receptor blockers and the development of ventilator-associated pneumonia in the intensive care unit: a retrospective cohort study. [PDF]

BMC Pulm Med
Cai H, Shen H, Cao X.
europepmc   +1 more source

Antihypertensive action and effects of MC-838,an angiotensin converting enzyme inhibitor,on the hemorrhagic shock in rats

, 1984
Yasuhiro Ohba, Junichiro Aono, Kazushige Sakai   +2 more
openalex   +1 more source

Systemic reactions to intravenous iron therapy in patients receiving angiotensin converting enzyme inhibitor [PDF]

, 1994
Giovanni Rolla, Caterina Bucca, Luisa Brussino   +2 more
openalex   +1 more source

Diagnostic value of computed tomography‐based muscle quality and metabolic signatures in heart failure with sarcopenia

ESC Heart Failure, EarlyView.
Abstract Aims Sarcopenia is a major comorbidity in heart failure (HF) patients, but its comprehensive evaluation remains challenging due to resource limitations. Computed tomography (CT) imaging allows opportunistic assessment of both muscle quantity and quality; however, its diagnostic utility and relationships with physical performance and underlying
Wataru Kawaharata, Hidemichi Kouzu, Keishi Ogura, Toshiyuki Yano, Satoshi Katano, Ryo Numazawa, Ryohei Nagaoka, Hiroki Aida, Katsuhiko Ohori, Ryo Nishikawa, Takefumi Fujito, Nobutaka Nagano, Marenao Tanaka, Masato Furuhashi   +13 more
wiley   +1 more source

Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes. [PDF]

Kidney Int Rep
Chen JJ, Lee CC, Yen CL, Fan PC, Chan MJ, Tsai TY, Chen YC, Yang CW, Chang CH.   +8 more
europepmc   +1 more source

Gastric and salivary mucins inhibit angiotensin-converting enzyme. Inhibition is partly due to oligosaccharides [PDF]

, 1992
E Schönherr, G A Jones, Linda L. Slakey
openalex   +1 more source

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Journal of the American College of Cardiology, 2005
J. Healey, A. Baranchuk, E. Crystal, C. Morillo, M. Garfinkle, S. Yusuf, S. Connolly   +6 more
semanticscholar   +1 more source

Clinical impact of tricuspid regurgitation in patients with acute myocardial infarction

ESC Heart Failure, EarlyView.
Abstract Aims The clinical impact of tricuspid regurgitation (TR) in patients after acute myocardial infarction (AMI) is largely unknown. The aim of this study was to clarify the prevalence and prognostic impact of TR in post‐AMI patients treated with appropriate primary percutaneous coronary intervention (PCI).
Shun Nishino, Chiharu Nishino, Michikazu Nakai, Kensaku Nishihira, Nehiro Kuriyama, Yoshisato Shibata   +5 more
wiley   +1 more source

Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. [PDF]

Cochrane Database Syst Rev
Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF.   +4 more
europepmc   +1 more source